Abstract
A group of children and adolescents with ADHD (25 boys and 9 girls), aged 6-17 years, were treated with strattera in the optimum dose (1,2 mg/day) on an outpatient basis. The assessment of treatment effectiveness showed the marked and moderately pronounced clinical effect in 78,1% patients after 3 months. The psychological study revealed a positive trend in the volume and speed of switching attention in 80% of children and the improvement of sustainability of attention - in 69%. Control EEG revealed the decrease in the <<index of deceleration>> in 70,2% of patients. Safety and good tolerance of strattera in the treatment of children and adolescents with ADHD were confirmed.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adolescent
-
Adrenergic Uptake Inhibitors / administration & dosage
-
Adrenergic Uptake Inhibitors / therapeutic use*
-
Atomoxetine Hydrochloride
-
Attention / drug effects*
-
Attention / physiology
-
Attention Deficit Disorder with Hyperactivity / drug therapy*
-
Attention Deficit Disorder with Hyperactivity / physiopathology
-
Attention Deficit Disorder with Hyperactivity / psychology
-
Child
-
Dose-Response Relationship, Drug
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Outpatients
-
Propylamines / administration & dosage
-
Propylamines / therapeutic use*
-
Treatment Outcome
Substances
-
Adrenergic Uptake Inhibitors
-
Propylamines
-
Atomoxetine Hydrochloride